OXYTOCIN 20 USP UNITS IN DEXTROSE 5% Drug Patent Profile
✉ Email this page to a colleague
When do Oxytocin 20 Usp Units In Dextrose 5% patents expire, and when can generic versions of Oxytocin 20 Usp Units In Dextrose 5% launch?
Oxytocin 20 Usp Units In Dextrose 5% is a drug marketed by Abbott and is included in one NDA.
The generic ingredient in OXYTOCIN 20 USP UNITS IN DEXTROSE 5% is oxytocin. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the oxytocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Oxytocin 20 Usp Units In Dextrose 5%
A generic version of OXYTOCIN 20 USP UNITS IN DEXTROSE 5% was approved as oxytocin by HIKMA on January 10th, 2007.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%?
- What are the global sales for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%?
- What is Average Wholesale Price for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%?
Summary for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 845 |
| DailyMed Link: | OXYTOCIN 20 USP UNITS IN DEXTROSE 5% at DailyMed |
Recent Clinical Trials for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Amsterdam | NA |
| Aarhus University Hospital | NA |
| University of Liverpool | NA |
See all OXYTOCIN 20 USP UNITS IN DEXTROSE 5% clinical trials
US Patents and Regulatory Information for OXYTOCIN 20 USP UNITS IN DEXTROSE 5%
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | OXYTOCIN 20 USP UNITS IN DEXTROSE 5% | oxytocin | INJECTABLE;INJECTION | 019185-002 | Mar 29, 1985 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
